Journal of Gastrointestinal Cancer

, Volume 43, Issue 1, pp 133–136 | Cite as

Gastric Adenocarcinoma? Looks Similar but Behaves Differently!

Letter to the Editor

References

  1. 1.
    Jang KY, Moon WS, Lee H, Kim CY, Park HS. Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma—a case report. Pathol Res Pract. 2010;206:387–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumours of the stomach. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumours of the digestive system. Lyon: IARC; 2000.Google Scholar
  3. 3.
    Solcia EKG, Sobin LH. Histological typing of endocrine tumors. World health organization international histological classification of tumors. 2nd ed. New York: Springer; 2000.Google Scholar
  4. 4.
    Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion. 1994;55 Suppl 3:11–23.PubMedCrossRefGoogle Scholar
  5. 5.
    Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.PubMedGoogle Scholar
  6. 6.
    Rindi G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol. 1995;19 Suppl 1:S20–9.PubMedGoogle Scholar
  7. 7.
    Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20:168–72.PubMedCrossRefGoogle Scholar
  8. 8.
    Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010–7.PubMedGoogle Scholar
  10. 10.
    Matsui K, Kitagawa M, Miwa A, Kuroda Y, Tsuji M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 1991;86:1167–75.PubMedGoogle Scholar
  11. 11.
    Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol. 2006;30:945–53.PubMedCrossRefGoogle Scholar
  12. 12.
    Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirii Y, Ichikawa C, Miyamoto M, et al. A case of gastric large cell neuroendocrine carcinoma (LCNEC) for whom chemotherapy of CDDP+CPT-11 proved very effective. Gan To Kagaku Ryoho. 2010;37:895–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Internal MedicineUniversity of ConnecticutFarmingtonUSA
  2. 2.Division of Hematology-Oncology, Department of Internal MedicineHartford HospitalHartfordUSA

Personalised recommendations